Promoter hypermethylation of multiple genes in primary gastric lymphoma

References

• Esteller M, Corn P G, Baylin S B, Herman J G. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225–3229
   PubMed Web of Science ®Google Scholar
• Herman J G, Baylin S B. Promoter region hypermethylation and gene silencing in human cancer. DNA Methylation and Cancer1st ed, PAJaPK Vogt. Springer-Verlag, New York 2000; 35–50
   Google Scholar
• Robertson K D, Jones P A. DNA methylation: past, present and future directions. Carcinogenesis 2000; 21: 461–467
   PubMed Web of Science ®Google Scholar
• Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncl 2003; 4: 351–358
   PubMed Web of Science ®Google Scholar
• Harris N L. Mature B-cell neoplasms. Pathology and Genetics: Tumor of Haematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein. IARC Press, Lyon 2001; 121–126, WHO Classification of Tumors
   Google Scholar
• Dolan M E, Schilsky R L. Silence is golden: gene hypermethylation and survival in large cell lymphoma. J Natl Cancer Inst 2002; 94: 6–7
   PubMed Web of Science ®Google Scholar
• Min K O, Seo E J, Kwon H J, Eui J L, Kim W I, Kang C S, et al. Methylation of p16INK4A and p57KIP2 are involved in the development and progression of gastric MALT lymphomas. Mod Pathol 2006; 19: 141–148
   PubMed Web of Science ®Google Scholar
• Go J H. Methylation analysis of cyclin-dependent kinase inhibitor genes in primary gastrointestinal lymphomas. Mod Pathol 2003; 16: 752–755
   PubMed Web of Science ®Google Scholar
• Takahashi T, Shivapurkar N, Reddy J, Shigematsu H, Miyajima K, Suzuki M, et al. DNA methylation profiles of lymphoid and hematopoietic malignancies. Clin Cancer Res 2004; 10: 2928–2935
   PubMed Web of Science ®Google Scholar
• Esteller M, Gaidano G, Goodman S N, Zagonel V, Capello D, Botto B, et al. Hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst 2002; 94: 26–32
   PubMed Web of Science ®Google Scholar
• Corn P G, Kuerbitz S J, van Noesel M M, Esteller M, Compitello N, Baylin S B, et al. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res 1999; 59: 3352–3356
   PubMed Web of Science ®Google Scholar
• Du M Q, Isaccson P G. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 2002; 3: 97–104
   PubMed Web of Science ®Google Scholar
• Willis T G, Jadayel D M, Du M Q, Peng H, Perry A R, Abdul-Rauf M, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999; 96: 35–45
   PubMed Web of Science ®Google Scholar
• Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi R A, Bearzi I, et al. t(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001; 98: 1182–1187
   PubMed Web of Science ®Google Scholar
• Streubel B, Lamprecht A, Dierlamm J, Cerroni L, Stolte M, Ott G, et al. t(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003; 101: 2335–2339
   PubMed Web of Science ®Google Scholar
• Sagaert X, De Wolf-Peeters C, Noels H, Baens M. The pathogenesis of MALT lymphomas: where do we stand?. Leukemia, advance online publication DOI: 10.1038/sj.leu.2404517
   Web of Science ®Google Scholar
• Ai L, Vo Q N, Zuo C, Li L, Ling W, Suen J Y, et al. Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidem Biomarkers & Prev 2004; 13: 150–156
   PubMed Web of Science ®Google Scholar
• Viswanathan M, Tsuchida N, Shanmugam G. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 2003; 105: 41–46
   PubMed Web of Science ®Google Scholar
• Fan C Y. Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications [Review]. Curr Oncol Rep 2004; 6: 152–161
   PubMedGoogle Scholar
• Ai L, Stephenson K K, Ling W, Chunlai Z, Mukunyadzi P, Suen J Y, et al. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod Pathol 2003; 16: 944–950
   PubMed Web of Science ®Google Scholar
• Huang Q, Ai L, Zhang Z Y, Fan C Y, Weiss L M. Promoter hypermethylation and protein expression of the p16 gene: analysis of 43 cases of B-cell primary gastric lymphomas from China. Mod Pathol 2004; 17: 416–422
   PubMed Web of Science ®Google Scholar
• Shiozawa E, Takimoto M, Makino R, Adachi D, Saito B, Yamochi-Onizuka T, et al. Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group. Leuk Res 2006; 30: 859–867
   Google Scholar
• Nakatsuka S, Takakuwa T, Tomita Y, Hoshida Y, Nishiu M, Yamaguchi M, et al. Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B cell but also in T- and natural killer (NK)/T-cell malignancies. Cancer Sci 2003; 94: 87–91
   PubMed Web of Science ®Google Scholar
• Nakatsuka S, Takakuwa T, Tomita Y, Hideaki M, Matsuzuka F, Aozasa K. Role of hypermethylation of DAP-kinase CpG island in the development of thyroid lymphoma. Lab Invest 2000; 80: 1651–1655
   PubMed Web of Science ®Google Scholar
• Esteller M, Garcia-Foncillas J, Andion E, Goodman S N, Hidalgo O F, Vanaclocha V, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343: 1350–1354
   PubMed Web of Science ®Google Scholar
• Tang X, Khuri F R, Lee J J, Kemp B L, Liu D, Hong W K, et al. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst 2000; 92: 1511–1516
   PubMed Web of Science ®Google Scholar
• Shiramizu B, Mick P. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma. Med Pediatr Oncol 2003; 41: 527–531
   PubMedGoogle Scholar
• Zuo C, Ai L, Ratliff P, Suen J Y, Hanna E, Brent T P, et al. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidem Biomarkers & Prev 2004; 13: 967–975
   PubMed Web of Science ®Google Scholar
• Ohno T, Hiraga J, Ohashi H, Sugisaki C, Li E, Asano H, et al. Loss of O6-methylguanine-DNA methyltransferase protein expression is a favorable prognostic marker in diffuse large B-cell lymphoma. Int J Hematol 2006; 83: 341–347
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Sakurai S, Hironaka M, Sato S, Oguni S, Sakuma Y, et al. Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas. Gut 2003; 52: 641–646
   PubMed Web of Science ®Google Scholar